Huntsville, AL., (December 3, 2024) – Curiteva, Inc., a privately held manufacturing and expertise firm, at present introduced it has implanted over 2,000 sufferers with the Encourage®C Cervical Interbody Fusion System. This success interprets to greater than 3,700 implants positioned, demonstrating the system’s fast adoption and effectiveness since its business launch in July 2023.
Chambliss Harrod, M.D., from The Backbone Middle Louisiana commented, “To mitigate the danger of pseudoarthrosis, I’ve utilized the Encourage Cervical implants to encourage fast bone development on and thru the fusion assemble. Anyplace there’s a physiologic interface the place you’re searching for a musculoskeletal re-enforcement or augmentation, utilizing the Encourage expertise permits for a possibility to have the bone not solely develop by way of but in addition maximally combine on and across the implant.”
“Surpassing 2,000 procedures with Encourage C Know-how showcases our vital development and future potential. Thanks to our staff, surgeons, traders, and distributor companions for working with us to succeed in this objective,” mentioned Chris Schultz, Curiteva’s Vice President of Advertising. “We look ahead to persevering with to ramp up our business efforts and are excited to see the broader affected person advantages now being recorded with the discharge of the Encourage lumbar portfolio.”
“Essentially the most thrilling factor about reaching this 2,000-patient milestone is realizing the excellent preliminary outcomes as our ongoing assortment of knowledge continues to validate and underscore the novelty of this Encourage Know-how,” commented Curiteva’s Chief Scientific Officer, Erik Erbe, PhD. “Most just lately the info was shared in ‘Distinctive Osseointegration Patterns in 3D Printed Trabecular-Structure Porous Polyetheretherketone (PEEK). A CT Scan Examine of the Encourage Cervical Implant’.”
The Encourage platform is manufactured with a proprietary, patented Fused Strand Deposition 3D printer designed, programmed, and constructed by Curiteva. This ground-breaking additive course of produces a completely interconnected and built-in porous construction traversing the whole implant designed to advertise osseointegration, enhance radiographic evaluation, and ship improved affected person outcomes. The primary-to-market mixture of the HAFUSE sub-micron floor texture and novel porous PEEK construction presents a hydrophilic, bioactive setting for cell attachment, proliferation, and therapeutic in pre-clinical animal and in vitro research.
Curiteva will probably be exhibiting on the Cervical Backbone Analysis Society (CSRS) annual assembly in Chicago subsequent month. “I encourage surgeons who’re considering studying extra concerning the Encourage 3D Printed Trabecular PEEK Know-how to go to us at Sales space 304,” added, Chris Schultz.
About Curiteva:
Curiteva is a privately held expertise and manufacturing firm based mostly in Huntsville, AL. Our enterprise is based on a dedication to constructing world-class manufacturing, accelerating analysis and growth, sustaining lean operational self-discipline, and delivering novel expertise to fulfill the evolving wants of our prospects and the sufferers they serve. Curiteva is pioneering 3D printing of Trabecular PEEK implants with a proprietary HAFUSE sub-micron floor designed to revolutionize how engineered buildings and implant biomaterials promote osseointegration, speed up therapeutic, and enhance affected person outcomes. For extra info, please go to www.curiteva.com
Discussion about this post